Abonnement à la biblothèque: Guest
Portail numérique Bibliothèque numérique eBooks Revues Références et comptes rendus Collections
International Journal of Medicinal Mushrooms
Facteur d'impact: 1.423 Facteur d'impact sur 5 ans: 1.525 SJR: 0.431 SNIP: 0.661 CiteScore™: 1.38

ISSN Imprimer: 1521-9437
ISSN En ligne: 1940-4344

Volumes:
Volume 21, 2019 Volume 20, 2018 Volume 19, 2017 Volume 18, 2016 Volume 17, 2015 Volume 16, 2014 Volume 15, 2013 Volume 14, 2012 Volume 13, 2011 Volume 12, 2010 Volume 11, 2009 Volume 10, 2008 Volume 9, 2007 Volume 8, 2006 Volume 7, 2005 Volume 6, 2004 Volume 5, 2003 Volume 4, 2002 Volume 3, 2001 Volume 2, 2000 Volume 1, 1999

International Journal of Medicinal Mushrooms

DOI: 10.1615/IntJMedMushrooms.2017024614
pages 1071-1081

Blood Glucose–Reducing and Fat-Reducing Effects of a Novel Medicinal Mushroom, Grifola gargal (Agaricomycetes)

Etsuko Harada
Faculty of Agriculture, Miyazaki University
Toshihiro Morizono
Department of Immunology, Mie University School of Medicine, Tsu, Mie, Japan
Masayoshi Saito
Department of Radiology, Graduate School of Medicine, Chiba University, Chiba, Japan

RÉSUMÉ

Grifola gargal Singer is a medicinal mushroom with biological effects such as antiatherogenic and antiosteoporotic activities. The objective of this study was to examine a blood glucose–reducing effect and a fatreducing effect of G. gargal supplementation in vivo. The effects of G. gargal powder (GGP) in a high–molecular weight hot water extract (GGH) and a low–molecular weight hot water extract (GGL) on blood glucose were investigated in streptozotocin (STZ)-induced diabetic ICR mice (STZ diabetic mice). A significant decrease in blood glucose was observed after 5 weeks of GGL supplementation (fraction with a molecular weight ≤ 6000 Da) in STZ diabetic mice. In the next test, we examined the antihyperglycemic and fat-reducing effects of GGL in diet-induced obesity (DIO) mice fed a high-fat diet. GGL facilitated reductions in blood glucose and body fat. This study confirms, to our knowledge for the first time, that administration of G. gargal extract has antihyperglycemic and body fat–reducing effects in STZ diabetic mice and DIO mice. Therefore, G. gargal is a promising functional food to prevent and treat diabetes and lifestyle-related diseases.


Articles with similar content:

Ethanolic Extract of the Golden Oyster Mushroom, Pleurotus citrinopileatus (Agaricomycetes), Alleviates Metabolic Syndrome in Diet-Induced Obese Mice
International Journal of Medicinal Mushrooms, Vol.19, 2017, issue 11
Changhui Zhao, Quanbo Chi, Kunlun Huang, Pengfei Shi, Guoyi Wang, Yao Sheng, Wentao Xu
Hypoglycemic and Hypolipidemic Effects of the Cracked-Cap Medicinal Mushroom Phellinus rimosus (Higher Basidiomycetes) in Streptozotocin-Induced Diabetic Rats
International Journal of Medicinal Mushrooms, Vol.17, 2015, issue 6
Thekkuttuparambil Ananthanarayanan Ajith, Kainoor K. Janardhanan, Kuttikkadan A. Rony
Antidiabetic Properties of the Tiger's Milk Medicinal Mushroom, Lignosus rhinocerotis (Agaricomycetes), in Streptozotocin-Induced Diabetic Rats
International Journal of Medicinal Mushrooms, Vol.19, 2017, issue 7
Szu Ting Ng, Cheng Fhai Chow, Chon Seng Tan, Kar Lin Nyam
Hypocholesterolemic Effect of the Oyster Mushroom, Pleurotus ostreatus (Jacq.:Fr.) P. Kumm. and Its Isolated Polysaccharides
International Journal of Medicinal Mushrooms, Vol.7, 2005, issue 3
Ayman S. Daba
Naringenin, a Citrus Flavonoid, Ameliorates Arsenic-Induced Toxicity in Swiss Albino Mice
Journal of Environmental Pathology, Toxicology and Oncology, Vol.33, 2014, issue 3
Ruma Das, Avratanu Das, Sanjib Bhattacharya, Amrita Roy, Sagnik Haldar, Pallab Kanti Haldar